Oxford Biomedica (LON:OXB) Share Price Passes Above 50-Day Moving Average – Should You Sell?

Oxford Biomedica plc (LON:OXBGet Free Report) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 420.59 ($5.29) and traded as high as GBX 426 ($5.36). Oxford Biomedica shares last traded at GBX 421.50 ($5.30), with a volume of 43,576 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft increased their price objective on Oxford Biomedica from GBX 250 ($3.15) to GBX 380 ($4.78) and gave the company a “hold” rating in a report on Tuesday, September 24th.

Check Out Our Latest Research Report on OXB

Oxford Biomedica Stock Performance

The stock has a market cap of £444.09 million, a PE ratio of -292.71 and a beta of 1.09. The stock has a fifty day moving average of GBX 420.59 and a 200-day moving average of GBX 371.98. The company has a quick ratio of 1.67, a current ratio of 2.35 and a debt-to-equity ratio of 154.88.

About Oxford Biomedica

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Featured Stories

Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.